Your browser doesn't support javascript.
loading
Applicability of the SPAN-100 index in a prospective and contemporary cohort of patients treated with intravenous rtPA in Catalonia. / Aplicabilidad del índice SPAN-100 en una cohorte prospectiva y contemporánea de pacientes tratados con rtPA por vía intravenosa en Cataluña.
Abilleira, S; Ribera, A; Quesada, H; Rubiera, M; Castellanos, M; Vargas, M; Gomis, M; Krupinski, J; Delgado-Mederos, R; Gómez-Choco, M; Giralt-Steinhauer, E; Garcia, M C; Pellisé, A; Purroy, F; Garcés, M; Gallofré, M.
Affiliation
  • Abilleira S; Plan Director de Enfermedades Cerebrovasculares, Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS), Barcelona, España. Electronic address: sabilleira@gencat.cat.
  • Ribera A; Unidad de Epidemiología Cardiovascular, Servicio de Cardiología, Hospital Vall d'Hebrón , Barcelona, España.
  • Quesada H; Servicio de Neurología, Hospital de Bellvitge, l'Hospitalet de Llobregat, Barcelona, España.
  • Rubiera M; Servicio de Neurología, Hospital Vall d'Hebrón, Barcelona, España.
  • Castellanos M; Servicio de Neurología, Hospital Josep Trueta, Girona, España.
  • Vargas M; Servicio de Neurología, Hospital Clínic, Barcelona, España.
  • Gomis M; Servicio de Neurología, Hospital Germans Trias, Badalona, España.
  • Krupinski J; Servicio de Neurología, Hospital Mútua de Terrassa, Terrassa, España.
  • Delgado-Mederos R; Servicio de Neurología, Hospital de Sant Pau, Barcelona, España.
  • Gómez-Choco M; Servicio de Neurología, Hospital Moisès Broggi, Sant Joan Despí, España.
  • Giralt-Steinhauer E; Servicio de Neurología, Hospital del Mar, Barcelona, España.
  • Garcia MC; Servicio de Neurología, Hospital Parc Taulí, Sabadell, España.
  • Pellisé A; Servicio de Neurología, Hospital Joan XXIII, Tarragona, España.
  • Purroy F; Servicio de Neurología, Hospital Arnau de Vilanova, Lleida, España.
  • Garcés M; Servicio de Neurología, Hospital Verge de la Cinta, Tortosa, España.
  • Gallofré M; Plan Director de Enfermedades Cerebrovasculares, Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS), Barcelona, España.
Neurologia ; 31(9): 592-598, 2016.
Article in En, Es | MEDLINE | ID: mdl-25542499
ABSTRACT

BACKGROUND:

Prognostic scales can be helpful for selecting patients for reperfusion treatment. This study aims to assess the prognostic ability of the recently published SPAN-100 index in a large cohort of stroke patients treated with intravenous thrombolysis (IV rtPA).

METHODS:

Using data from the prospective registery of all reperfusion treatments administered in Catalonia, we selected patients treated with IV rtPA alone between 2011 and 2012. The SPAN-100 index was calculated as the sum of age (years) and NIHSS score, and patients in the cohort were classified as SPAN-100 positive [≥ 100] or SPAN-100 negative [< 100]. We measured raw and adjusted rates of symptomatic intracerebral haemorrhage (SICH), mortality, and 3-month functional outcome (mRS 0-2) for each SPAN-100 category. Area under the ROC curve was calculated to predict the main outcome measures.

RESULTS:

We studied 1685 rtPA-treated patients, of whom 1405 (83%) were SPAN-100 negative. The SICH rates adjusted for sex, pre-stroke mRS, hypertension, diabetes, dyslipidaemia, ischaemic heart disease, heart failure, atrial fibrillation, prior TIA/stroke and time to thrombolysis did not differ between groups, but likelihood of functional independence (mRS 0-2) at 3 months was nearly 8 times higher in the SPAN-100 negative group than in the positive group. Furthermore, the 3-month mortality rate was 5 times higher in the SPAN-100 positive group. ROC curve analysis showed high specificities for predicting both functional independence and 3-month mortality for a cut-off point of 100.

CONCLUSION:

The SPAN-100 index is a simple and straightforward method that may be useful for selecting candidates for rtPA treatment in doubtful cases, and for informing patients and their relatives about likely outcomes.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombolytic Therapy / Outcome Assessment, Health Care / Tissue Plasminogen Activator / Stroke / Fibrinolytic Agents Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male Country/Region as subject: Europa Language: En / Es Journal: Neurologia Journal subject: NEUROLOGIA Year: 2016 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombolytic Therapy / Outcome Assessment, Health Care / Tissue Plasminogen Activator / Stroke / Fibrinolytic Agents Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male Country/Region as subject: Europa Language: En / Es Journal: Neurologia Journal subject: NEUROLOGIA Year: 2016 Document type: Article